FDA finalizes definition of biologics, prepping entry of insulin biosimilars
US FDA announces updated definition of a biologic medicine, ahead of insulin, and other products, transitioning to become licensed as biologics.
Archives for February 25, 2020
GSK partnership deal signals further intent on cancer
The company signs a deal with Immatics for the development of TCR therapeutics targeting solid tumors.